Immunogenicity and Safety of Sabin-IPV Replacement Vaccination

NCT04051736 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
360
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

China National Biotec Group Company Limited

Collaborators